Biotech companies at AACR 2027
Apr 2–7, 2027 Orlando, FL ~23k attendees Website
5 biotech companies are at AACR 2027 — 5 with a booth in the exhibit hall. 5 of them have their own page in this guide. As of Sep 27, 2026.
Showing 1–5 of 5 organizations
| Organization | AACR 2027 Attendance |
|---|---|
Eilean Therapeutics Dover, DE | |
Clinical-stage small-molecule oncology developer targeting drug-resistance mechanisms in blood cancers and solid tumors, including KRAS, menin and BCL2 programs. | Booth Exhibiting at Booth 1657 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Fore Biotherapeutics Philadelphia, PA | |
Clinical-stage company developing plixorafenib, a next-generation BRAF inhibitor that avoids paradoxical MAPK activation, in a phase 2 basket trial for BRAF-altered cancers. | Booth Exhibiting at Booth 2107 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Insilico Medicine Cambridge, MA | |
Drug developer that uses its own generative-AI platform for target discovery, molecule design and clinical planning to build a pipeline of new drug candidates. | Booth Exhibiting at Booth 907 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Revolution Medicines Redwood City, CA | |
Oncology drug developer in late-stage trials with RAS(ON) inhibitors aimed at the many oncogenic RAS variants that drive RAS-addicted cancers. | Booth Exhibiting at Booth 2607 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Syncromune Fort Lauderdale, FL | |
Clinical-stage developer of SYNC-T, an intratumoral immunotherapy combining partial tumor freezing with an infused immunomodulatory drug, in Phase 2 for metastatic solid tumors. | Booth Exhibiting at Booth 2661 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Instantly find 20 buyers from biotech companies
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse AACR 2027 by
Organization type
Focus
- Genomics and sequencing 82
- Imaging, spatial biology and pathology 59
- Drug discovery and screening 58
- Antibodies and recombinant proteins 52
- Tumor models and cell culture 45
- Immuno-oncology 36
- AI and data 28
- Single-cell analysis and flow cytometry 26
- Liquid biopsy 26
- Targeted therapy 21
- Clinical trials 21
- Proteomics and protein analysis 20
- Cell and gene therapy 19
- Antibody-drug conjugates 18
- Biospecimens and biobanking 17
Exhibit hall
Everyone
Not affiliated with the American Association for Cancer Research. Organization details are derived from AACR’s published exhibitor list. Submit a correction